Robert Paul

Nessuna posizione attualmente

58 anni

Health Technology

Consumer Services

Profilo

Robert Paul formerly worked at Nine Square Therapeutics, Inc., as Chief Executive Officer from 2022 to 2025, Genentech, Inc., as Assistant Director-Group Medical from 2015 to 2016, and Alector, Inc., as Chief Medical Officer from 2016 to 2021.
Dr. Paul received his doctorate degree from Ludwig-Maximilians-Universität München.

Precedenti posizioni note di Robert Paul

Società	Posizione	Fine
Nine Square Therapeutics, Inc. Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Amministratore Delegato	01/02/2025
ALECTOR, INC.	Direttore Tecnico/Scientifico/R&S	11/10/2021
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Corporate Officer/Principal	01/10/2016

Vedi nel dettaglio l'esperienza di Robert Paul

Formazione di Robert Paul

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Robert Paul

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alector, Inc. Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders	Health Technology
Nine Square Therapeutics, Inc. Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Health Technology